Superbugs show need for new approaches and new antibiotics
Health professionals have also announced that this superbug existence demonstrates that there is a desperate need for new approaches and new antibiotics in the medical industry. Only when the approaches and treatments have changed will patients be able to fight off the superbugs.
One of these superbugs is a specific strain of urinary tract infection, called gram-negative bacteria. It has developed resistance to colistin, which is typically used as a last-resort treatment for several multidrug-resistant organisms.
In addition, over 50,000 health care-associated Pseudomonas aeruginosa infections happen every year; approximately 13 percent are multidrug-resistant infections.
Reuters recently published an article that informed Pennsylvania of a local superbug.
"Many drugmakers have been reluctant to spend the money needed to develop new antibiotics, preferring to use their resources on medicines for cancer and rare diseases that command very high prices and lead to much larger profits,” the Reuters writer said.
To resolve this problem, doctors must prescribe fewer antibiotics for everyday illnesses that have other treatments available. This new approach will help to prevent further bacteria from developing resistance while scientists create new treatments for diseases.